Open AccessUse of nitric oxide in thoracic surgery for a high risk cardiac patient
Author(s) -
Vishal Garg,
Sheikh Salahuddin Ahmed,
Steven Stamenkovic
Publication year - 2014
Publication title -
annals of cardiac anaesthesia/annals of cardiac anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 27
eISSN - 0974-5181
pISSN - 0971-9784
DOI - 10.4103/0971-9784.129882
Subject(s) - medicine , ventricle , cardiology , perfusion , nitric oxide , pulmonary artery , ejection fraction , pulmonary hypertension , cardiac surgery , cardiac output , anesthesia , blood pressure , heart failure
Nitric oxide (NO) is a selective pulmonary vasodilator especially in the presence of pulmonary artery hypertension. With right ventricle (RV) dysfunction, inhaled NO may increase RV ejection fraction and cardiac output. The main advantage of NO over intravenous therapy is its inability to decrease systemic pressure thereby maintaining the coronary perfusion pressure and the myocardial perfusion. In this case report, we discuss the use of NO in a routine thoracic surgery patient suffering with severe left ventricular dysfunction and a potential candidate for a very high cardiac risk.